ATI RN
ATI Pharmacology 2023 Questions
Extract:
Question 1 of 5
A nurse is reviewing the medication administration record for a client who has cancer and is receiving morphine via a PCA pump. Which of the following prescriptions should the nurse clarify with the provider?
Correct Answer: A
Rationale: The correct answer is A: Nalbuphine. The nurse should clarify this prescription because nalbuphine is an opioid analgesic antagonist. Co-administration with morphine, an opioid agonist, can lead to decreased analgesic effects and potential opioid withdrawal symptoms. Acetaminophen (
B) is a non-opioid analgesic and does not interact significantly with morphine. Ondansetron (
C) is an antiemetic commonly used with opioids to prevent nausea and vomiting. Insulin glargine (
D) is a long-acting insulin used to manage diabetes and does not have a direct interaction with morphine.
Question 2 of 5
A nurse is assessing a client who has heart failure and is taking furosemide. Which of the following findings should indicate to the nurse that the client is experiencing fluid volume deficit?
Correct Answer: D
Rationale: The correct answer is D: Elevated hematocrit level. In fluid volume deficit, there is a decrease in fluid volume in the body leading to increased concentration of red blood cells, resulting in an elevated hematocrit level. This occurs because the body is trying to compensate for the decreased fluid volume by increasing the concentration of red blood cells in the blood.
Weight gain (
A) is a sign of fluid volume excess, not deficit. Distended neck veins (
B) are a sign of fluid volume overload, typically seen in heart failure. Shortness of breath (
C) is a common symptom of heart failure but not specific to fluid volume deficit.
Question 3 of 5
A nurse is developing a teaching plan for an older adult client who has a new prescription for insulin glargine. Which of the following expected outcomes should the nurse include in the plan?
Correct Answer: D
Rationale: The correct answer is D: The client will wear his reading glasses when drawing up a dose of insulin glargine. This is important to ensure accurate dosage measurement and injection technique, preventing medication errors. Option A is incorrect as insulin glargine is usually given once daily, not before each meal. Option B is incorrect because the deltoid muscle is not a recommended site for insulin injection due to inconsistent absorption. Option C is incorrect as additional doses should not be taken without consulting healthcare provider. Option D is correct as it emphasizes safety and accuracy in insulin administration.
Question 4 of 5
A nurse is preparing to administer the varicella vaccine to a group of clients. The nurse should identify which of the following clients as having a contraindication for receiving this immunization?
Correct Answer: D
Rationale: The correct answer is D: A client who has AIDS. Clients with AIDS have compromised immune systems, making them more vulnerable to potential complications from live vaccines like the varicella vaccine. The live varicella vaccine could lead to serious infections in individuals with weakened immune systems.
Incorrect
Choices:
A: An older adult client living in a long-term care facility - Advanced age alone is not a contraindication for varicella vaccine.
B: A young adult who has an allergy to eggs - The varicella vaccine is not contraindicated in individuals with egg allergies.
C: A child who recently received the human papillomavirus vaccine - There is no contraindication for receiving the varicella vaccine after the HPV vaccine.
Question 5 of 5
A nurse is caring for a client who is receiving ondansetron IV. Which of the following findings is an indication that the ondansetron is effective?
Correct Answer: A
Rationale: The correct answer is A: Decreased nausea. Ondansetron is an antiemetic medication used to treat nausea and vomiting.
Therefore, a decrease in nausea indicates that the medication is effective in managing the client's symptoms. Reduced dizziness (
B) and absence of peripheral neuropathy (
D) are not directly related to the action of ondansetron. Increased urinary output (
C) is not a typical effect of ondansetron.